ReviewInternational journal of oncology2021

Immune-checkpoint inhibitors from cancer to COVID‑19: A promising avenue for the treatment of patients with COVID‑19 (Review).

Silvia Vivarelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.